Neuro-Oncology· 2021Q1· Review
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- 11,963citations
- Q1SCImago
- 2021year
Short summary
The 2021 fifth edition of the WHO Classification of Tumors of the CNS introduces major changes, significantly advancing the role of molecular diagnostics alongside traditional histology and immunohistochemistry.
AI-generated from the title and abstract; the full text is not read.
Key points
- Integrates molecular diagnostics (e.g., DNA methylome profiling) with histology and immunohistochemistry.
- Introduces new CNS tumor types and subtypes.
- Establishes new approaches to CNS tumor nomenclature and grading.
- Emphasizes the importance of integrated diagnoses and layered reports.
AI-generated from the title and abstract; the full text is not read.
Abstract
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth edition introduces major changes that advance the role of molecular diagnostics in CNS tumor classification. At the same time, it remains wedded to other established approaches to tumor diagnosis such as histology and immunohistochemistry. In doing so, the fifth edition establishes some different approaches to both CNS tumor nomenclature and grading and it emphasizes the importance of integrated diagnoses and layered reports. New tumor types and subtypes are introduced, some based on novel diagnostic technologies such as DNA methylome profiling. The present review summarizes the major general changes in the 2021 fifth edition classification and the specific changes in each taxonomic category. It is hoped that this summary provides an overview to facilitate more in-depth exploration of the entire fifth edition of the WHO Classification of Tumors of the Central Nervous System.
The authors' abstract, as published at the source. Neuro-Oncology, 2021 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Genetics (Medicine)
GeneticsMedicine